Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
Launched by IMPERIAL COLLEGE LONDON · Apr 25, 2022
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether wearing graduated compression stockings helps prevent blood clots in patients who are at low risk after having short surgeries. Blood clots can form in the legs and travel to the lungs, where they can be very dangerous. While these stockings are commonly used in hospitals to help reduce this risk, it's unclear if they are truly helpful for patients who are not at high risk of developing clots. Given that many patients undergo short surgeries each year and often wear these stockings, this study aims to find out if they are necessary for low-risk patients.
To participate in this study, individuals need to be adults aged 18 to 59 scheduled for surgery with a hospital stay of less than 48 hours and assessed as low-risk for blood clots. Those who qualify will be asked to wear the compression stockings during their hospital stay. The study will help determine if continuing to use these stockings is worthwhile, which could impact treatment practices and costs in the future. If you're considering participating, it’s important to know that there are certain health conditions that would exclude you from the trial, such as having a history of blood clots or needing specific treatments for blood clot prevention.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (18-59 years of age) scheduled to undergo a surgical procedure with a hospital stay \<48 hours
- • Individuals assessed as being at low-risk of developing VTE as per the DHRA Tool (i.e. no assessed thrombosis risk factors / scoring 0)
- Exclusion Criteria:
- • Individuals with a contraindication to GCS
- • Individuals assessed as being at moderate or high-risk of VTE as per the DHRA tool
- • Individuals requiring therapeutic anticoagulation
- • Individuals with thrombophilia/ thrombogenic disorder
- • Individuals with a previous history of VTE
- • Individuals requiring intermittent pneumatic compression therapy beyond theatre and recovery
- • Individuals requiring extended thromboprophylaxis beyond discharge
- • Female patients of childbearing age who have a positive pregnancy test
- • Individuals with lower limb immobilisation
- • Inability to provide informed consent
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, United Kingdom
Middlesbrough, United Kingdom
Barnsley, United Kingdom
Stockton On Tees, United Kingdom
East Grinstead, United Kingdom
Camberley, United Kingdom
London, United Kingdom
Nottingham, United Kingdom
Taunton, United Kingdom
Patients applied
Trial Officials
Alun Davies
Principal Investigator
Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials